Please login to the form below
Webinar: The value and effective use of RWE in pricing and market access
Thursday 4th February at 2pm UK/9am EST
Real World Evidence (RWE) has become vital to support and enhance market access and pricing. But what is the value of RWE, what are the shortcomings, and how can you effectively use it? Join us for the latest in the Expert Insights webinar series, where Raf De Wilde, our Senior Executive Advisor will be joined by our expert panel to discuss how to optimise RWE to support market access and pricing.
Panelists
Jim Ballenger: Chief Pharmacy Officer for Ohio, US and Principal of BallengeRx Consulting
Company Details
Valid Insight
+44 (0) 20 3750 9833
Address:
152-160 City Road
Kemp House
London
EC1V 2NX
United Kingdom
Latest content on this profile
- Valid Insight are hiring Market Access Writers (Senior Consultant – Payer Value Communication)
- We are currently looking for an experienced market access writer for a full-time permanent role as a Senior Consultant - Payer Value Communication.
Valid Insight
- Webinar: The value and effective use of RWE in pricing and market access
Valid Insight
- Webinar: Maintaining market access through a pandemic, 6 months on
- In this webinar, Valid Insight explore market access and how it has evolved through a pandemic over the past 6 months.
Valid Insight
- Webinar: How to develop an optimal value story for your product
- This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
- Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
- How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
- Are biobetters a market access opportunity?
- Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
